BHC - Bausch Health Companies Inc logo

BHC

Bausch Health Companies Inc

Bausch Health Companies Inc. develops, manufactures, and markets pharmaceuticals and medical devices across gastroenterology, dermatology, neurology, and eye health. It serves customers globally, generating revenue from its diverse product portfolio.

โš•๏ธ Healthcare NYSE Listed 1994 $ USD
$1,000 invested 30 years ago โ†’$1,451today

Score Overview

1 Year
Score
Net Growth-6x
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth3.43%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.3
Net Growth-14.14%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth28.10%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth55.08%
Net Trend60%
Net Income Consistency
Rev Growth11.68%
Rev Trend60%
Revenue Consistency
20 Years
Score3.5
Net Growth-5x
Net Trend45%
Net Income Consistency
Rev Growth10x
Rev Trend65%
Revenue Consistency
30 Years
Score
Net Growth-47x
Net Trend53%
Net Income Consistency
Rev Growth162x
Rev Trend77%
Revenue Consistency
All Time
Score
Net Growth-113x
Net Trend53%
Net Income Consistency
Rev Growth624x
Rev Trend78%
Revenue Consistency

See the full market ranking โ†’

Bausch Health Companies Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 8.02B to $ 10.44B and net income went from -$ 559M to $ 159M. Revenue increased in 4 of those 5 years; net income in 3.

Across Bausch Health Companies Inc's full reported history, from 1994 to 2025, revenue grew from $ 17M to $ 10.44B and net income grew from $ 9M to $ 159M. Revenue increased in 78% of the years measured; net income in 53%.

Bausch Health Companies Inc currently holds a 20-year HDB Score of 3.5 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 6.21โ€”
1 Year2025-08-12
$ 7.00-11.29%
5 Years2021-08-12
$ 27.14-77.12%
10 Years2016-08-12
$ 24.92-75.08%
20 Years2006-08-11
$ 10.80-42.50%
30 Years1996-08-12
$ 4.2845.12%
All Time1994-03-29
$ 0.3418x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 10.80B-$ 1.08B$ 900M
2025$ 10.44B$ 159M$ 1.32B
2024$ 9.62B-$ 46M$ 1.18B
2023$ 8.75B-$ 592M$ 947M
2022$ 8.12B-$ 225M$ 564M
2021$ 8.43B-$ 948M$ 582M
2020$ 8.02B-$ 559M$ 605M
2019$ 8.60B-$ 1.78B$ 3.24B
2018$ 8.38B-$ 4.14B$ 721M
2017$ 8.72B$ 2.40B$ 720M
2016$ 9.67B-$ 2.40B$ 542M
2015$ 10.44B-$ 268M$ 597M
2014$ 8.20B$ 881M$ 322M
2013$ 5.76B-$ 866M$ 600M
2012$ 3.48B-$ 116M$ 920M
2011$ 2.46B$ 159M$ 170M
2010$ 1.14B-$ 208M$ 400M
2009$ 820M$ 176M$ 114M
2008$ 757M$ 199M$ 318M
2007$ 842M$ 195M$ 437M
2006$ 1.07B$ 210M$ 834M
2005$ 935M$ 246M$ 445M
2004$ 886M$ 160M$ 39M
2003$ 823M-$ 40M$ 133M
2002$ 788M$ 87M$ 56M
2001$ 583M$ 87M$ 434M
2000$ 309M-$ 147M$ 125M
1999$ 176M$ 62M$ 244M
1998$ 112M$ 45M$ 78M
1997$ 82M$ 35M$ 8M
1996$ 66M$ 22M$ 4M
1995$ 20M$ 5M$ 24M
IPO1994$ 17M$ 9M$ 2M

Explore beyond BHC

You're looking at Bausch Health Companies Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies